EN
HI
Cohance Lifesciences share price chart
Cohance Lifesciences Share Key Metrics
Volume
15.08 L
Market Cap
17414.46 CR
LTQ@LTP
3@455.20
ATP
458.49
Var Margin
23.01 %
Circuit Range
355.8-533.7
Delivery %
29.64 %
Value
69.13 CR
ASM/GSM
No
Market Lot
1
Summary
COHANCE stock price is ₹455.2 as of 18 Aug, 2026. The stock intraday movement has stayed between ₹444.75 and ₹466.90, while Cohance Lifesciences share price 52 week high low is ₹266.70 & ₹1038.90.
In terms of trading activity, COHANCE share price has recorded a volume of 15,07,812 shares. The Cohance Lifesciences has a market cap of ₹382567140. The stock’s Average Traded Price (ATP) stands at ₹458.49, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 3 @ ₹455.20.
The Cohance Lifesciences upper circuit limit is ₹533.70 & The Cohance Lifesciences lower circuit limit is ₹355.80, with a Value of ₹69.13 CR. The Delivery Percentage for the day is 29.64%.
Additionally, the share currently falls under the No framework, and trades with a market lot size of ₹1.
Cohance Lifesciences Fundamentals
P/E Ratio
160.16
P/B Ratio
4.4
Div. Yield
0
Sector P/E
63.29
Sector P/B
3.31
Sec. Div. Yield
0.51
Cohance Lifesciences Resistance and Support
Pivot 447.45
Resistance
First Resistance
457.1
Second Resistance
469.45
Third Resistance
479.1
Support
First Support
435.1
Second Support
425.45
Third Support
413.1
Cohance Lifesciences Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Tue Aug 18 2026 | 444.95 | 455.2 | 2.35% | 466.9 | 444.75 |
| Mon Aug 17 2026 | 439.1 | 444.75 | 0.93% | 459.79 | 437.79 |
| Fri Aug 14 2026 | 444.95 | 440.64 | -0.80% | 448.7 | 438.5 |
Cohance Lifesciences Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-05 | Quarterly Results |
| 2026-05-12 | Audited Results |
| 2026-02-12 | Quarterly Results |
| 2025-11-12 | Quarterly Results |
| 2025-08-13 | Quarterly Results |
| 2025-05-28 | Audited Results |
| 2025-02-12 | Quarterly Results |
| 2024-11-12 | Quarterly Results |
| 2024-08-09 | Quarterly Results |
Cohance Lifesciences News
Cohance Lifesciences Ltd - 543064 - Announcement under Regulation 30 (LODR)-Credit Rating
Cohance Lifesciences announced that CRISIL Ratings has withdrawn credit ratings for certain lower-limit facilities. The company requested the withdrawal, stating that other ratings from India Ratings continue to cover its higher-limit facilities, ensuring no impact on existing credit or borrowing arrangements.
Aug 13 2026 12:35:57
Cohance Lifesciences Ltd - 543064 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
DSP Trustee Private Limited and its associated funds (DSP Mutual Fund, DSP Alternative Investment Fund, DSP Global Funds ICAV) sold 2,899,996 shares, representing 0.76% of Cohance Lifesciences' total share capital. This reduces their combined stake from 4.29% to 3.53%. The transaction occurred through the open market.
Aug 12 2026 11:10:12
Read More
Cohance Lifesciences Management
| Name | Position |
|---|---|
| Umang Vohra | Chairman |
| Himanshu Agarwal | Whole Time Director |
Cohance Lifesciences Similar Stocks
Caplin Point Laboratories Ltd.
2529.70
7.70 (0.31%)
Eris Lifesciences Ltd.
1350.10
1.20 (0.09%)
Poly Medicure Ltd.
1784.70
51.10 (2.95%)
Onesource Specialty Pharma Ltd.
1542.30
-15.90 (1.02%)
Alembic Pharmaceuticals Ltd.
824.55
2.10 (0.26%)
Natco Pharma Ltd.
898.35
8.55 (0.96%)
Shilpa Medicare Ltd.
809.80
0.50 (0.06%)
Dr. Agarwal's Health Care Ltd.
502.60
1.00 (0.20%)
Cohance Lifesciences FAQs
The Buying Price of Cohance Lifesciences share is 455.2 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Cohance Lifesciences stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Cohance Lifesciences, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Cohance Lifesciences shares is 160.16. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Cohance Lifesciences shares is 4.4. Useful to assess the stock's value relative to its book value.
To assess Cohance Lifesciences’s valuation compare Sector P/E, P/B which are 63.29 & 3.31 with sector averages, along with growth rates and financial metrics.
The Market Cap of Cohance Lifesciences is 17414.46 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Cohance Lifesciences share price is 1038.90 & 266.70. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Cohance Lifesciences belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
